| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.097 | 0.08 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.086 | 0.08 |